This study aimed at examining the cardioprotective effects of resveratrol in rats with simultaneous type 2 diabetes and renal hypertension. Eight groups (8-10 each) of male Sprague-Dawley rats, including a control, a diabetic, a renal hypertensive, a sham, a simultaneously hypertensive–diabetic receiving vehicle, and 3 simultaneously hypertensive-diabetic receiving resveratrol at 5, 10 or 20 mg/kg/day were used. After 4 weeks of treatment, blood pressure and glucose, and serum markers of oxidative stress were measured, and animals’ hearts were used for isolated studies. Resveratrol prevented the increase of systolic blood pressure, serum malondialdehyde, fasting blood glucose, infarct size, coronary resistance, and coronary effluent creatine kinase-MB. Moreover, it prevented the decrease of serum superoxide dismutase and glutathione reductase, heart rate, left ventricular developed pressure, rate of increase of ventricular pressure, and rate of decrease of ventricular pressure. In conclusion, our findings show that resveratrol alleviates cardiac dysfunction in diabetic-hypertensive rats by virtue of antioxidant, antihypertensive, and coronary vasodilating activities.
RushJW, QuadrilateroJ, LevyAS, FordRJ. (2007) Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Experimental Biology and Medicine, 232, 814–822.
2.
MokniM, LimamF, ElkahouiS, AmriM, AouaniE. (2007) Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury. Archives of Biochemistry and Biophysics, 457, 1–6.
3.
DurhamKK, SmithCS, RushJW. (2011) Chronic resveratrol treatment alleviates myocardial ischemia injury in a hypertensive model. The Journal of the Federation of American Societies for Eeperimental Biology, 25, 611–639.
4.
DernekS, IkizlerM, ErkasapN, ErgunB, KokenT, YilmazK, SevinB, KaygisizZ, KuralT. (2004) Cardioprotection with resveratrol pretreatment: improved beneficial effects over standard treatment in rat hearts after global ischemia. Scandinavian Cardiovascular Journal, 38, 245–254.
5.
LiuZ, SongY, ZhangX, LiuZ, ZhangW, MaoW, WangW, CuiW, ZhangX, JiaX. (2005) Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model. Clinical and Experimental Pharmacology and Physiology, 32, 1049–1054.
6.
PalsamyP, SubramanianS. (2010) Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic β-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. Journal of Cellular Physiology, 224, 423–432.
7.
SuH-C, HungL-M, ChenJ-K. (2006) Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. American Journal of Physiology-Endocrinology and Metabolism, 290, E1339–E1346.
8.
MaH-j, CaoY-k, LiuY-x, WangR, WuY-m. (2008) Microinjection of resveratrol into rostral ventrolateral medulla decreases sympathetic vasomotor tone through nitric oxide and intracellular Ca2+ in anesthetized male rats. Acta Pharmacologica Sinica, 29, 906–912.
9.
SzkudelskiT, SzkudelskaK. (2011) Anti-diabetic effects of resveratrol. Annals of the New York Academy of Sciences, 1215, 34–39.
10.
NekooeianAA, KhaliliA, KhosraviMB. (2014) Effects of short-term renovascular hypertension and type 2 diabetes on cardiac functions in rats. Iranian Journal of Medical Sciences, 39, 51–59.
11.
ThirunavukkarasuM, PenumathsaSV, KoneruS, JuhaszB, ZhanL, OtaniH, BagchiD, DasDK, MaulikN. (2007) Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase. Free Radical Biology and Medicine, 43, 720–729.
12.
NishioS, TeshimaY, TakahashiN, ThucLC, SaitoS, FukuiA, KumeO, FukunagaN, HaraM, NakagawaM. (2012) Activation of CaMKII as a key regulator of reactive oxygen species production in diabetic rat heart. Journal of Molecular and Cellular Cardiology, 52, 1103–1111.
13.
MazzantiL, RabiniRA, FaloiaE, FumelliP, BertoliE, De PirroR. (1990) Altered cellular Ca2+ and Na+ transport in diabetes mellitus. Diabetes, 39, 850–854.
14.
CerielloA, QuagliaroL, D'AmicoM, Di FilippoC, MarfellaR, NappoF, BerrinoL, RossiF, GiuglianoD. (2002) Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes, 51, 1076–1082.
15.
SinghVP, LeB, KhodeR, BakerKM, KumarR. (2008) Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes, 57, 3297–3306.
16.
NekooeianAA, KhaliliA, KhosraviMB. (2014) Effects of oleuropein in rats with simultaneous type 2 diabetes and renal hypertension: a study of antihypertensive mechanisms. Journal of Asian Natural Products Research, 16, 1–10.
17.
DasS, DasDK. (2007) Anti-inflammatory responses of resveratrol. Inflammation and Allergy Drug Targets (Formerly Current Drug Targets-Inflammation and Allergy), 6, 168–173.
18.
NovakovicA, BukaricaLG, KanjuhV, HeinleH. (2006) Potassium channels-mediated vasorelaxation of rat aorta induced by resveratrol. Basic and Clinical Pharmacology and Toxicology, 99, 360–364.
19.
ChenC-J, YuW, FuY-C, WangX, LiJ-L, WangW. (2009) Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1–FoxO1 pathway. Biochemical and Biophysical Research Communications, 378, 389–393.
20.
LiY, CaoZ, ZhuH. (2006) Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacological Research, 53, 6–15.
21.
UngvariZ, OroszZ, RiveraA, LabinskyyN, XiangminZ, OlsonS, PodlutskyA, CsiszarA. (2007) Resveratrol increases vascular oxidative stress resistance. American Journal of Physiology-Heart and Circulatory Physiology, 292, H2417–H2424.
22.
MizutaniK, IkedaK, KawaiY, YamoriY. (2001) Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clinical and Experimental Pharmacology and Physiology, 28, 55–59.
23.
NekooeianAA, KhaliliA, KhosraviMB. (2014) Oleuropein offers cardioprotection in rats with simultaneous type 2 diabetes and renal hypertension. Indian Journal of Pharmacology, 46, 398–403.
